Transforming smartphones into active sonar systems to detect opioid overdose
将智能手机转变为主动声纳系统以检测阿片类药物过量
基本信息
- 批准号:9906080
- 负责人:
- 金额:$ 22.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Opioid use disorder (OUD) and mortality from opioid overdose are significant public health concerns. Deaths
from opioid overdose are highly preventable with early detection and administration of naloxone. A key challenge
of the epidemic is that overdose victims often die because they are alone or among untrained or impaired
bystanders and thus do not receive timely resuscitation. There is an urgent, unmet need for a low-barrier, easily
scalable solution that can identify opioid overdoses in real-time and rapidly connect victims to naloxone therapy.
The goal of Sound Life Sciences’ (SLS) Fast-Track proposal is to commercialize an innovative overdose
detection software product that can be downloaded on any commodity smartphone and can detect opioid-
induced respiratory failure (i.e., overdose) and summon help. The software-only product, SecondChance,
converts a smartphone into a short-range active sonar system capable of monitoring breathing and detecting
overdose. SecondChance requires no additional hardware and leverages the native speaker/microphone array
inside the phone and proprietary overdose detection signal processing algorithms. The software enables an
individual to monitor themselves when they are at risk for an overdose and, in the event of an overdose,
SecondChance can summon help, either from a friend or family member or from emergency medical services
(EMS). Sound Life Sciences’ long-term goal is to keep individuals with OUD safe until they are able to access
treatment and achieve durable recovery. In Phase I of this Fast-Track application, SLS will convert the
SecondChance prototype (for which feasibility has been established) into a minimum viable product (MVP) based
on rapid iteration guided by feedback and usability testing. In Phase II, using human factors engineering
approaches, SLS will complete the SecondChance System and systematically validate each component: the
patient monitoring app, the HIPAA-compliant data collection and storage infrastructure, and the emergency
services integration. The Phase II studies will culminate in a 510(k) submission to the FDA. The SecondChance
System will be marketed to naloxone manufacturers, local governments and people with OUD to ensure rapid
dissemination to at-risk individuals. Given the number of people with OUD and costs associated with opioid
overdose, there is a substantial market for the SecondChance System.
项目摘要/摘要
阿片类药物使用障碍(OUD)和阿片类药物过量的死亡率是公共卫生的重大问题。死亡人数
通过早期检测和纳洛酮给药可预防阿片类药物的过量。一个关键的挑战
流行病是因为滥用过量通常是因为他们是一个人或未经训练或受损
旁观者,因此没有及时复苏。对于低障碍,很容易满足的紧急,未满足的需求
可扩展的溶液可以实时鉴定阿片类药物过量并迅速连接到纳洛酮治疗的惊喜。
声音生命科学的目标(SLS)快速提案是商业化的过量
可以在任何商品智能手机上下载的检测软件产品,并且可以检测到Ooid-
诱发呼吸衰竭(即过量)和召唤帮助。仅软件的产品,第二次,
将智能手机转换为一个能够监视呼吸和检测的短距离活动声纳系统
过量。第二次不需要其他硬件,并且要利用母语/麦克风阵列
在手机内部和专有的过量检测信号处理算法。该软件使
当他们有过量的风险时,个人可以监视自己,并且在服用过量时,
第二次Chance可以从朋友或家人或紧急医疗服务召唤帮助
(EMS)。 Sound Life Sciences的长期目标是确保个人安全,直到能够访问
治疗并实现持久的恢复。在此快速轨道应用程序的第一阶段,SLS将转换
第二个原型(已建立可行性)为最低可行产品(MVP)
在反馈和可用性测试的指导下快速迭代。在第二阶段,使用人为因素工程
方法,SLS将完成第二次体系系统,并系统地验证每个组件:
患者监控应用程序,符合HIPAA的数据收集和存储基础架构以及出现
服务集成。 II期研究将在510(k)提交FDA中达到高潮。第二次
系统将被销售给纳洛酮制造商,地方政府和拥有OUD的人,以确保快速
向高危个人传播。鉴于与OOPOID相关的OUD人数和成本
服用过量,第二次体系有一个巨大的市场。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
相似国自然基金
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
资源受限下集成学习算法设计与硬件实现研究
- 批准号:62372198
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于物理信息神经网络的电磁场快速算法研究
- 批准号:52377005
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
考虑桩-土-水耦合效应的饱和砂土变形与流动问题的SPH模型与高效算法研究
- 批准号:12302257
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向高维不平衡数据的分类集成算法研究
- 批准号:62306119
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Low-Cost Mobile Detection of Opioid Overdose Events
阿片类药物过量事件的低成本移动检测
- 批准号:98910489891048
- 财政年份:2019
- 资助金额:$ 22.35万$ 22.35万
- 项目类别:
Low-Cost Mobile Detection of Opioid Overdose Events
阿片类药物过量事件的低成本移动检测
- 批准号:1035865210358652
- 财政年份:2019
- 资助金额:$ 22.35万$ 22.35万
- 项目类别:
Overlay independent X-ray data analysis for enhanced oxime OP-ChE reactivation
叠加独立 X 射线数据分析,增强肟 OP-ChE 重新激活
- 批准号:93563459356345
- 财政年份:2016
- 资助金额:$ 22.35万$ 22.35万
- 项目类别:
Overlay independent X-ray data analysis for enhanced oxime OP-ChE reactivation
叠加独立 X 射线数据分析,增强肟 OP-ChE 重新激活
- 批准号:92093369209336
- 财政年份:2016
- 资助金额:$ 22.35万$ 22.35万
- 项目类别:
Clinical and Genetic Predictors of Unstable Warfarin Response
华法林反应不稳定的临床和遗传预测因素
- 批准号:85377878537787
- 财政年份:2012
- 资助金额:$ 22.35万$ 22.35万
- 项目类别: